Jiangsu Xiuqiang Glasswork (300160.SZ) expects a net profit of 200 million to 240 million yuan in 2024.
Xiuhao Shares (300160.SZ) released the annual performance forecast for 2024, with the company expecting a net profit for the year of...
Jiangsu Xiuqiang Glasswork (300160.SZ) released its 2024 annual performance forecast, with the company expecting a net profit attributable to shareholders of the listed company of 2 billion to 2.4 billion yuan in 2024; after deducting non-recurring gains and losses, the net profit is expected to be 1.82 billion to 2.28 billion yuan.
Related Articles
On September 16th, LIVZON PHARMA (01513) spent 3.6914 million yuan to repurchase 92,100 A-shares.
Jiangxi Synergy Pharmaceutical (300636.SZ) has obtained the European Pharmacopoeia Certification.
Shanghai Shyndec Pharmaceutical (600420.SH) : The Injection of Pentobarbital Sodium has obtained a drug registration certificate.
On September 16th, LIVZON PHARMA (01513) spent 3.6914 million yuan to repurchase 92,100 A-shares.
Jiangxi Synergy Pharmaceutical (300636.SZ) has obtained the European Pharmacopoeia Certification.
Shanghai Shyndec Pharmaceutical (600420.SH) : The Injection of Pentobarbital Sodium has obtained a drug registration certificate.
